Estimating tulathromycin withdrawal time in pigs using a physiologically based pharmacokinetics model

References

• Benchaoui HA, Nowakowski M, Sherington J, Rowan TG, Sunderland SJ. 2004. Pharmacokinetics and lung tissue concentrations of tulathromycin in swine. J Vet Pharmacol Ther. 27:203–210.
   PubMed Web of Science ®Google Scholar
• Buur J, Baynes R, Smith G, Riviere J. 2006. Use of probabilistic modeling within a physiologically based pharmacokinetic model to predict sulfamethazine residue withdrawal times in edible tissues in swine. Antimicrob Agents Chemother. 50:2344–2351.
   PubMed Web of Science ®Google Scholar
• Buur JL, Baynes RE, Craigmill AL, Riviere JE. 2005. Development of a physiologic-based pharmacokinetic model for estimating sulfamethazine concentrations in swine and application to prediction of violative residues in edible tissues. Am J Vet Res. 66:1686–1693.
   PubMed Web of Science ®Google Scholar
• Buur JL, Baynes RE, Riviere JE. 2008. Estimating meat withdrawal times in pigs exposed to melamine contaminated feed using a physiologically based pharmacokinetic model. Regul Toxicol Pharmacol. 51:324–331.
   PubMed Web of Science ®Google Scholar
• Chiesa OA, Li H, Kijak PJ, Li JX, Lancaster V, Smith ML, Heller DN, Thomas MH, Von Bredow J. 2012. Tissue/fluid correlation study for the depletion of sulfadimethoxine in bovine kidney, liver, plasma, urine, and oral fluid. J Vet Pharmacol Ther. 35:249–258.
   PubMed Web of Science ®Google Scholar
• Chiesa OA, Von Bredow J, Heller D, Nochetto C, Smith M, Moulton K, Thomas M. 2006. Use of tissue-fluid correlations to estimate gentamicin residues in kidney tissue of Holstein steers. J Vet Pharmacol Ther. 29:99–106.
   PubMed Web of Science ®Google Scholar
• Chiesa OA, Von Bredow J, Smith M, Heller D, Condon R, Thomas MH. 2006. Bovine kidney tissue/biological fluid correlation for penicillin. J Vet Pharmacol Ther. 29:299–306.
   PubMed Web of Science ®Google Scholar
• Clothier KA, Kinyon JM, Griffith RW. 2012. Antimicrobial susceptibility patterns and sensitivity to tulathromycin in goat respiratory bacterial isolates. Vet Microbiol. 156:178–182.
   PubMed Web of Science ®Google Scholar
• Committee for Veterinary Medicinal Products. Guideline on injection site. [Internet]. 2005. CVMP: EMA; [cited 2012 Sept 30]. Available from: http://www.ema.europa.eu/ docs/en_GB/document_library/Scientific_guideline/2009/10/WC500004429.pdf
   Google Scholar
• Committee for Veterinary Medicinal Products. Note for Guidance: Approach Towards Harmonisation of Withdrawal Periods [Internet]. 1996. CVMP: EMA; [cited 2012 Sept 30]. Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/Scientific_guideline/2009/10/WC500004428.pdf
   Google Scholar
• Cox SR, McLaughlin C, Fielder AE, Yancey MF, Bowersock TL, Garcia-Tapia D, Bryson L, Lucas MJ, Robinson JA, Nanjiani I, et al. 2010. Rapid and prolonged distribution of tulathromycin into lung homogenate and pulmonary epithelial lining fluid of holstein calves following a single subcutaneous administration of 2.5 mg/kg body weight. Int J Appl Res Vet M. 8:129–137.
   Web of Science ®Google Scholar
• Craigmill AL. 2003. A physiologically based pharmacokinetic model for oxytetracycline residues in sheep. J Vet Pharmacol Ther. 26:55–63.
   PubMed Web of Science ®Google Scholar
• EMA. Annex 1 Summary of product characteristics. [Internet]. 2003. EMA; [cited 2012 Sept 30]. Available from: http://ec.europa.eu/health/documents/community-register/2003/200311117074/anx_7074_en.pdf
   Google Scholar
• EMA. Committee for Veterinary Medicinal Products: Tulathromycin (summary report 2). [Internet]. 2004. EMA; [cited 2012 Sept 30]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_- _Report/2009/11/WC500015754.pdf
   Google Scholar
• Feng Q, Gao T, Ji H, Jiang X, Liang T, Gu W, Wu G, Gao G, Wang W. 2010. Kinetic analysis of oxytetracycline residues in Chinese mitten crab, Eriocheir sinensis, muscle following intramuscular administration. J Fish Dis. 33:639–647.
   PubMed Web of Science ®Google Scholar
• Gallo JM, Lam FC, Perrier DG. 1987. Area method for the estimation of partition coefficients for physiological pharmacokinetic models. J Pharmacokinet Biopharm. 15:271–280.
   PubMedGoogle Scholar
• Godinho KS, Keane SG, Nanjiani IA, Benchaoui HA, Sunderland SJ, Jones MA, Weatherley AJ, Gootz TD, Rowan TG. 2005. Minimum inhibitory concentrations of tulathromycin against respiratory bacterial pathogens isolated from clinical cases in European cattle and swine and variability arising from changes in in vitro methodology. Vet Ther. 6:113–121.
   PubMed Web of Science ®Google Scholar
• Huang XH, Zhao YD, He LM, Liang ZS, Guo LL, Zeng ZL, Chen ZL, Zhang M, Fang BH. 2012. Development of high performance liquid chromatography-tandem mass spectrometry method for the detection of tulathromycin in swine plasma. J Integr Agri. 11:465–473.
   Google Scholar
• Illambas J, Potter T, Rycroft A, Lees P. 2009. Pharmacodynamics of tulathromycin in vitro and ex vivo against calf pathogens. J Vet Pharmacol Ther. 32:62–63.
   PubMed Web of Science ®Google Scholar
• Kanzenbach S, Lahrmann KH. 2011. Efficiency and economy of metaphylaxis with a single dose injection of Tulathromycin in weaned piglets of an Actinobacillus pleuropneumoniae problem herd. Tieraerztl Umschau. 66:112–117.
   Web of Science ®Google Scholar
• Langhoff R, Stuckler T, Ladinig A, Barz A, Spergser J, Palzer A, Ritzmann M. 2012. Investigation about the effects of tulathromycin (Draxxin®) against Mycoplasma hyorhinis in a field trial. Tieraerztl Umschau. 67:3–9.
   Web of Science ®Google Scholar
• Leavens TL, Tell LA, Clothier KA, Griffith RW, Baynes RE, Riviere JE. 2012. Development of a physiologically based pharmacokinetic model to predict tulathromycin distribution in goats. J Vet Pharmacol Ther. 35:121–131.
   PubMed Web of Science ®Google Scholar
• MacLachlan DJ. 2009. Influence of physiological status on residues of lipophilic xenobiotics in livestock. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 26:692–712.
   PubMed Web of Science ®Google Scholar
• MacLachlan DJ. 2010. Physiologically based pharmacokinetic (PBPK) model for residues of lipophilic pesticides in poultry. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 27:302–314.
   PubMed Web of Science ®Google Scholar
• Mercer HD, Baggot JD, Sams RA. 1977. Application of pharmacokinetic methods to the drug residue profile. J Toxicol Environ Health. 2:787–801.
   PubMed Web of Science ®Google Scholar
• Nanjiani IA, Basano FS, Nazzari R, Toni F, Miotto L. 2010. Comparative efficacy of tulathromycin vs. florfenicol/flunixin combination in bovine respiratory disease (BRD) associated with mannheimia haemolytica, pasteurella multocida and histophilus somni, on Italian commercial farms. Cattle Pract. 18:38–39.
   Web of Science ®Google Scholar
• Nanjiani IA, McKelvie J, Benchaoui HA, Godinho KS, Sherington J, Sunderland SJ, Weatherley AJ, Rowan TG. 2005. Evaluation of the therapeutic activity of tulathromycin against swine respiratory disease on farms in Europe. Vet Ther. 6:203–213.
   PubMed Web of Science ®Google Scholar
• Ni HJ, Huang XH, He LM, Fang BH, Zhao YD. 2011. Determination of tulathromycin residues in swine tissues. Chinese J Anim Vet Sci. 42:557–561 (in Chinese).
   Google Scholar
• Nowakowski MA, Inskeep PB, Risk JE, Skogerboe TL, Benchaoui HA, Meinert TR, Sherington J, Sunderland SJ. 2004. Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triamilide antibiotic, in cattle. Vet Ther. 5:60–74.
   PubMed Web of Science ®Google Scholar
• Peters SA. 2012. Variability, uncertainty, and sensitivity analysis. In: Physiologically-based pharmacokinetic (PBPK) modeling and simulations: Principles, methods, and applications in the pharmaceutical industry. Hoboken (NJ): Wiley; p. 172–173.
   Google Scholar
• Upton RN. 2008. Organ weights and blood flows of sheep and pig for physiological pharmacokinetic modelling. J Pharmacol Toxicol Methods. 58:198–205.
   PubMedGoogle Scholar
• Walker CC, Thune RL, Barker SA. 1995. Plasma/muscle ratios of sulfadimethoxine residues in channel catfish (Ictalurus punctatus). J Vet Pharmacol Ther. 18:306–310.
   PubMed Web of Science ®Google Scholar
• Yang F, Liu HW, Li M, Ding HZ, Huang XH, Zeng ZL. 2012. Use of a Monte Carlo analysis within a physiologically based pharmacokinetic model to predict doxycycline residue withdrawal time in edible tissues in swine. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 29:73–84.
   PubMed Web of Science ®Google Scholar
• Yuan LG, Luo XY, Zhu LX, Wang R, Liu YH. 2011. A physiologically based pharmacokinetic model for valnemulin in rats and extrapolation to pigs. J Vet Pharmacol Ther. 34:224–231.
   PubMed Web of Science ®Google Scholar
• Zhao YD, Liu SS, Jiao XJ, Ni HJ, Yu HM, He XR, Wang SF, Zeng ZL, Huang XH. 2011. Pharmacokinetic and bioavailability study of tulathromycin in swine. Sci Agric Sin. 44:823–828 (in Chinese).
   Google Scholar